Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 99-0617795 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To advance safe and responsible Psychotropic Deprescribing through research and education in best clinical practices. To accomplish this the organization intends to unite those medical professionals professional organizations patient advocates and other parties concerned about Psychotropic Deprescribing. Major activities will be research meetings research seminars and publications to inform medical professionals and the general public.
Total Revenue
$52K
FY2024
Total Expenses
$3K
FY2024
Net Assets
$50K
Program Ratio
32.5%
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.